Adrenal Imaging Strategies: Which and When

Friday, May 13, 2022

11:00 AM – 12:00 PM

Location: Breakout Room 5-Aqua DEF (Level 3)

Speaker(s)

Michael Blake, MD
Attending Radiologist
Massachusetts General Hopsital
Milton, Massachusetts, United States

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

PDF Slides

Moderator(s)

Irina Bancos, MD
Associate Professor
Mayo Clinic
Rochester, Minnesota, United States

Disclosure: Adrenas (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Corcept (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); HRA Pharma (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Recordati (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 10/2021); Sparrow Pharmaceutics (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Spruce (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)

Learning Objectives:

Differentiate an adrenal adenoma from a non-adenoma on imaging studies
Recognize the imaging features of pheochromocytomas
Recognize the imaging features of adrenal cortical carcinomas

Participants should be aware of the following financial/non-financial relationships:

Michael Blake, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Irina Bancos, MD: Adrenas (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Corcept (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); HRA Pharma (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Recordati (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Sparrow Pharmaceutics (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Spruce (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards)